Ferenc Renyi-Vamos
Research Subjects
Research Interests
Ferenc Renyi-Vamos has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Balazs Dome
Department of Thoracic Surgery, Semmelweis University and National Institute of Oncology, Budapest, Hungary; National Koranyi Institute of Pulmonology, Budapest, Hungary; Department of Thoracic Surgery, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria; Department of Translational Medicine, Lund University, Lund, Sweden
1 shared publication - Gábor Kovács
Natl Koranyi Inst Pulmonol, Budapest, Hungary
1 shared publication - József Tóvári
Department of Experimental Pharmacology and the National Tumor Biology Laboratory, National Institute of Oncology, 1122 Budapest, Hungary
1 shared publication - Krisztina Bogos
Tumor Biology, Budapest, Hungary
1 shared publication
Latest Publications
- Open Access
- 14 July 2008
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 27 (1) , 18-7
Role of retinoic receptors in lung carcinogenesis
Several in vitro and in vivo studies have examined the positive and negative effects of retinoids (vitamin A analogs) in premalignant and malignant lesions. Retinoids have been used as chemopreventive and anticancer agents because of their pleiotropic regulator function in cell differentiation, growth, proliferation and apoptosis through interaction with two types of nuclear receptors: retinoic acid receptors and retinoid X receptors. Recent investigations have gradually elucidated the function of retinoids and their signaling pathways and may explain the failure of earlier chemopreventive studies.
- 14 July 2008
- Published by Springer Nature in Journal of Experimental & Clinical Cancer Research
- Vol. 27 (1) , 18-7
Open AccessRole of retinoic receptors in lung carcinogenesis
Several in vitro and in vivo studies have examined the positive and negative effects of retinoids (vitamin A analogs) in premalignant and malignant lesions. Retinoids have been used as chemopreventive and anticancer agents because of their pleiotropic regulator function in cell differentiation, growth, proliferation and apoptosis through interaction with two types of nuclear receptors: retinoic acid receptors and retinoid X receptors. Recent investigations have gradually elucidated the function of retinoids and their signaling pathways and may explain the failure of earlier chemopreventive studies.